4
Changes in Ownership
Ensysce Biosciences, Inc. Filed Acc 0001192482-21-000614
Options or other derivatives
- Chief Business Officer acquired 1,386,730 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Wright Richard Chester · Chief Business Officer
Table II: Derivative
5 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-06-30 | Grant or award : show line 1 in the form Stock Option | +49,975 | 49,975 | D |
| 2021-06-30 | Grant or award : show line 2 in the form Stock Option | +65,850 | 65,850 | D |
| 2021-06-30 | Grant or award : show line 3 in the form Stock Option | +263,400 | 263,400 | D |
| 2021-06-30 | Grant or award : show line 4 in the form Stock Option | +19,755 | 19,755 | D |
| 2021-06-30 | Grant or award : show line 5 in the form Stock Option | +987,750 | 987,750 | D |
Loading xslF345X03/edgar.xml…